Abstract
Mouse embryonic fibroblasts (MEFs) that lack p53 are hypersensitive to the cytotoxic and genotoxic effect of ultraviolet (UV-C) light. They also display a defect in the recovery from UV-C-induced DNA replication inhibition. An enzyme involved in processing stalled DNA replication forks is flap endonuclease 1 (Fen1). Gene expression profiling of UV-C-irradiated MEFs revealed fen1 to be upregulated, which was confirmed by RT–PCR and Western blot experiments. Increased Fen1 levels upon UV-C exposure are due to transcriptional activation, as revealed by inhibitor studies. Fen1 induction was dose- and time-dependent; it occurred on protein level already 3 h after irradiation. Induction of Fen1 by UV-C requires p53 since it was observed in p53 wild-type (wt) but not in p53 null (p53−/−) fibroblasts. Fen1 upregulation paralleled the increase in p53 protein level in replicating wt cells, whereas in nonreplicating cells both Fen1 and p53 were not induced by UV-C. The mouse fen1 promoter was cloned and shown to harbor a p53 consensus sequence to which p53 binds. In cotransfection experiments, p53 stimulated the expression of a fen1 promoter–reporter construct. Transgenic expression of Fen1 in p53 null cells attenuated UV-C light-induced DNA replication inhibition, supporting the hypothesis that Fen1 induction is involved in the recovery of cells from DNA damage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bae SH, Bae KH, Kim JA and Seo YS . (2001). Nature, 412, 456–461.
Bartek J, Lukas C and Lukas J . (2004). Nat. Rev. Mol. Cell Biol., 5, 792–804.
Chan GL, Doetsch PW and Haseltine WA . (1985). Biochemistry, 24, 5723–5728.
Chehab NH, Malikzay A, Stavridi ES and Halazonetis TD . (1999). Proc. Natl. Acad. Sci. USA, 96, 13777–13782.
Christmann M and Kaina B . (2000). J. Biol. Chem., 275, 36256–36262.
Christmann M, Tomicic MT and Kaina B . (2002). Nucleic. Acids Res., 30, 1959–1966.
Christmann M, Tomicic MT, Roos WP and Kaina B . (2003). Toxicology, 193, 3–34.
Cistulli CA and Kaufmann WK . (1998). Cancer Res., 58, 1993–2002.
el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B . (1992). Nat. Genet., 1, 45–49.
Gottifredi V, Shieh S, Taya Y and Prives C . (2001). Proc. Natl. Acad. Sci. USA, 98, 1036–1041.
Grombacher T, Eichhorn U and Kaina B . (1998). Oncogene, 17, 845–851.
Haas S and Kaina B . (1995). Carcinogenesis, 16, 985–991.
Harrington JJ and Lieber MR . (1994). EMBO J., 13, 1235–1246.
Hawkins DS, Demers GW and Galloway DA . (1996). Cancer Res., 56, 892–898.
Henneke G, Koundrioukoff S and Hubscher U . (2003). Oncogene, 22, 4301–4313.
Janus F, Albrechtsen N, Dornreiter I, Wiesmuller L, Grosse F and Deppert W . (1999). Cell Mol. Life Sci., 55, 12–27.
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW . (1991). Cancer Res., 51, 6304–6311.
Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y and Shkedy D . (1999). Proc. Natl. Acad. Sci. USA, 96, 14973–14977.
Kim IS . (1998). Exp. Mol. Med., 30, 252–256.
Klungland A and Lindahl T . (1997). EMBO J., 16, 3341–3348.
Lackinger D, Eichhorn U and Kaina B . (2001). Mutagenesis, 16, 233–241.
Lackinger D and Kaina B . (2000). Mutat. Res., 457, 113–123.
Lakin ND and Jackson SP . (1999). Oncogene, 18, 7644–7655.
Larsen E, Gran C, Saether BE, Seeberg E and Klungland A . (2003). Mol. Cell. Biol., 23, 5346–5353.
Maltzman W and Czyzyk L . (1984). Mol. Cell. Biol., 4, 1689–1694.
Prasad R, Dianov GL, Bohr VA and Wilson SH . (2000). J. Biol. Chem., 275, 4460–4466.
Prost S, Ford JM, Taylor C, Doig J and Harrison DJ . (1998). J. Biol. Chem., 273, 33327–33332.
Ruggiero BL and Topal MD . (2004). J. Biol. Chem., 279, 23088–23097.
Rumbaugh JA, Henricksen LA, DeMott MS and Bambara RA . (1999). J. Biol. Chem., 274, 14602–14608.
Sharma S, Otterlei M, Sommers JA, Driscoll HC, Dianov GL, Kao HI, Bambara RA and Brosh Jr RM . (2004). Mol. Biol. Cell, 15, 734–750.
Shi BS, Yu YN, Cai ZN and Shen BH . (2001). Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 33, 309–314.
Shibata Y and Nakamura T . (2002). J. Biol. Chem., 277, 746–754.
Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC and Fornace Jr AJ . (2000). Mol. Cell. Biol., 20, 3705–3714.
Tomicic MT, Friedrichs C, Christmann M, Wutzler P, Thust R and Kaina B . (2003). Mol. Pharmacol., 63, 439–449.
Warbrick E, Coates PJ and Hall PA . (1998). J. Pathol., 186, 319–324.
Zheng L, Zhou M, Chai Q, Parrish J, Xue D, Patrick SM, Turchi JJ, Yannone SM, Chen D and Shen B . (2005). EMBO Rep., 6, 83–89.
Acknowledgements
This work was supported by Deutsche Forschungsgemeinschaft (KA724 and SFB 432).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Christmann, M., Tomicic, M., Origer, J. et al. Fen1 is induced p53 dependently and involved in the recovery from UV-light-induced replication inhibition. Oncogene 24, 8304–8313 (2005). https://doi.org/10.1038/sj.onc.1208994
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208994
Keywords
This article is cited by
-
YY1 suppresses FEN1 over-expression and drug resistance in breast cancer
BMC Cancer (2015)
-
Delayed c-Fos activation in human cells triggers XPF induction and an adaptive response to UVC-induced DNA damage and cytotoxicity
Cellular and Molecular Life Sciences (2011)
-
Transcriptomic changes arising during light-induced sporulation in Physarum polycephalum
BMC Genomics (2010)